Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has provided an update.
ASKA Pharmaceutical Holdings Co., Ltd. has announced the introduction of response policies to address the large-scale purchase of its shares by Dalton Investments and associated entities. This move is aimed at safeguarding the company’s corporate value and the interests of its shareholders, as Dalton’s shareholding has increased significantly, raising concerns over potential control over the company’s financial and business policies.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is based in Tokyo, Japan, and is listed on the Tokyo Stock Exchange under the ticker TSE:4886.
Average Trading Volume: 43,591
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen64.64B
For a thorough assessment of 4886 stock, go to TipRanks’ Stock Analysis page.